Patrick C. Dolder
- Clinical Psychology top 0.5%
- Psychedelics and Drug Studies 37
- Toxicology top 0.5%
- Forensic Toxicology and Drug Analysis 9
-
- Neurotransmitter Receptor Influence on Behavior 23
- Biological Psychiatry top 5%
- Organic Chemistry top 2%
- Chemical synthesis and alkaloids 13
-
- Biochemical Analysis and Sensing Techniques 8
-
- Cannabis and Cannabinoid Research 4
-
- Neuroendocrine regulation and behavior 3
-
- Plant and fungal interactions 3
- Co-authors
- Matthias E. LiechtiYasmin SchmidFelix MüllerStefan BorgwardtFriederike HolzeKatharina RentschKim P. C. KuypersNatasha L. Mason
- Journals
- Psychopharmacology (5 papers)The International Journal of Neuropsychopharmacology (4 papers)European Neuropsychopharmacology (3 papers)
- Partner nations
- SwitzerlandNetherlandsGermany
In The Last Decade
Patrick C. Dolder
43 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Clinical Psychology 2.0k
- Toxicology 306
- Cellular and Molecular Neuroscience 1.3k
- Biological Psychiatry 141
- Organic Chemistry 1.1k
Countries citing papers authored by Patrick C. Dolder
This map shows the geographic impact of Patrick C. Dolder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. Dolder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. Dolder more than expected).
Fields of papers citing papers by Patrick C. Dolder
This network shows the impact of papers produced by Patrick C. Dolder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. Dolder. The network helps show where Patrick C. Dolder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick C. Dolder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Studybreakdown → | 2022 | 172 |
| 3 | 2021 | 40 | |
| 4 | 2020 | 65 | |
| 5 | 2020 | 178 | |
| 6 | 2020 | 23 | |
| 7 | 2020 | 11 | |
| 8 | 2019 | 49 | |
| 9 | 2018 | 14 | |
| 10 | 2018 | 115 | |
| 11 | 2017 | 92 | |
| 12 | 2017 | 37 | |
| 13 | 2017 | 100 | |
| 14 | 2017 | 35 | |
| 15 | 2017 | 97 | |
| 16 | 2016 | 18 | |
| 17 | 2016 | 155 | |
| 18 | 2015 | 81 | |
| 19 | 2015 | 37 | |
| 20 | 2014 | 40 |
About Patrick C. Dolder
Patrick C. Dolder is a scholar working on Toxicology, Clinical Psychology and Cellular and Molecular Neuroscience, having authored 43 papers that have together received 2.5k indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (37 papers), Neurotransmitter Receptor Influence on Behavior (23 papers), Chemical synthesis and alkaloids (13 papers), Forensic Toxicology and Drug Analysis (9 papers), Biochemical Analysis and Sensing Techniques (8 papers), Cannabis and Cannabinoid Research (4 papers), Neuroendocrine regulation and behavior (3 papers) and Plant and fungal interactions (3 papers). The work is most often cited by research in Clinical Psychology (2.0k citations), Toxicology (306 citations) and Cellular and Molecular Neuroscience (1.3k citations). Patrick C. Dolder has collaborated with scholars based in Switzerland, Netherlands and Germany. Frequent co-authors include Matthias E. Liechti, Yasmin Schmid, Felix Müller, Stefan Borgwardt, Friederike Holze, Katharina Rentsch, Kim P. C. Kuypers, Natasha L. Mason, Nadia R. P. W. Hutten and Johannes G. Ramaekers. Their work appears in journals such as Psychopharmacology, The International Journal of Neuropsychopharmacology, European Neuropsychopharmacology, Neuropsychopharmacology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.